$UL

Unilever Share Price Target Lifted at BofA, TD Cowen Following Strong Q2 Results

Unilever’s Q2 results beat expectations, prompting price target increases from TD Cowen and BofA. TD Cowen raised its target to $76 from $67, citing a 5.8% volume-led sales beat and EPS of EUR 1.61 vs EUR 1.59 consensus, and said management gained confidence to lift its H2 outlook. BofA lifted its target to $76 from $72 and raised EPS estimates for 2026-2028.

Original reporting
Published Jul 29, 2026, 3:53 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 4:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Unilever Share Price Target Lifted at BofA, TD Cowen Following Strong Q2 Results — source image
Decision brief

The 30-second read

$ULBullishMed
01

Why it matters

Two analysts raised price targets to $76 and BofA increased EPS estimates for 2026-2028 by 1% each, citing volume/mix outperformance and confidence in a higher H2 sales outlook.

02

Market read

The key tradable input is the convergence of bullish sell-side revisions to $76, anchored to specific Q2 beat metrics and an implied H2 outlook raise.

03

What to watch

The article does not quantify the magnitude or timing of the raised H2 sales outlook, nor does it address valuation or margin sustainability, which could drive follow-through versus mean reversion.

Relevance 7/10Novelty 6/10Timing: same-day analyst price target increases after Q2 results

Background

Unilever reported a better-than-expected Q2 with a volume-led sales beat and slightly higher EPS, prompting sell-side optimism.

Company-level read

Ticker impact

$ULBullishMedium confidence
Context

Unilever shares saw two same-day price target lifts after a better-than-expected Q2 volume-led sales beat and EPS outperformance.

Expected impact

Bias modestly positive for the next few sessions as the market digests the raised outlook and higher EPS estimates.

Evidence & confidence

The article provides concrete analyst target changes ($67 to $76, $72 to $76) tied to specific Q2 metrics (volume-led sales beat 5.8% vs 4.3% consensus; EPS EUR 1.61 vs EUR 1.59) and an implied H2 outlook raise, but it is still analyst-driven rather than a new company filing.

Market effects

Reinforces positive read-through for consumer staples names when volume-led growth and profitability beats translate into raised outlooks.

May support UK-listed consumer staples sentiment given the ADR weakness despite the analyst upgrades.

Limited beyond large-cap consumer goods, since the catalyst is company-specific earnings performance and sell-side revisions.

Counterpoint

Target lifts may already be partially priced in after the Q2 beat, so incremental upside could be capped if subsequent quarters fail to sustain volume/mix strength.

Key entities

  • Unilever

    Consumer goods company whose Q2 results triggered analyst target increases and EPS estimate revisions.

  • TD Cowen

    Raised its Unilever price target to $76 from $67, maintaining a Buy rating.

  • BofA

    Raised its Unilever price target to $76 from $72 and increased EPS estimates for 2026-2028 by 1% each.

Related articles

$ULMed

JPMorgan places 2 European staples stocks on positive catalyst watch

JPMorgan upgraded Reckitt to Overweight and placed Heineken and Unilever on positive catalyst watch, citing potential upside in earnings and growth. The firm expects high-single-digit EPS growth for the sector, with food and HPC companies at 6%-7%, beer at 7%-8%, and spirits at 3%-4%. JPMorgan sees cautious optimism for the second half of the year, supported by emerging-market momentum and other factors.

$ULMedAI 9/10

One of Norfolk's most famous brands has been put up for sale

Colman's Mustard is up for sale as part of a £48bn merger between Unilever and McCormick. Unilever seeks to address competition concerns by selling the brand, which has never had a foreign owner. McCormick already owns French’s Mustard. Unilever aims to focus on home and personal care products.

$ULMedAI 9/10

Unilever eyes sale of Colman’s mustard

Unilever is selling Colman's mustard brand to address competition concerns ahead of its £34b food division merger with McCormick, expected to generate $20b in 2025 revenue. Unilever will receive $15.7b and a 9.9% stake in the new company. No valuation for Colman's has been disclosed yet.

$ULMedAI 8/10

Unilever puts Colman’s up for sale amid competition concerns

Unilever is selling its Colman’s brand to address competition concerns related to its £33 billion food division sale to McCormick. The sale includes brands like Marmite and Knorr, while Unilever focuses on beauty and personal care. Colman’s, a UK mustard leader, is being marketed by Rothschild, with valuation unclear. Unilever shareholders will retain 65% in the new McCormick-Unilever Foods entity.